Edwards Lifesciences (EW) Stock Analysis
This is a peer-relative look at Edwards Lifesciences (EW): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Health Care Equipment & Services peers, so every number reads in context rather than in isolation.
Company Profile
| Profile Item | EW |
|---|---|
| Name | Edwards Lifesciences Corporation |
| Country/Region | United States |
| GICS Sector | Health Care |
| GICS Industry Group | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment |
| Market Capitalization | 58.73 billion USD |
| Currency | USD |
| Exchange | NYSE |
| Listing Date | March 27, 2000 |
| Security Type | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| Total Return (1Y) | 25.08% | 21.53% |
| Total Return (3Y, Annualized) | 17.28% | 9.81% |
| Total Return (5Y, Annualized) | -2.77% | -2.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| Volatility (1Y, Annualized) | 25.58% | 50.93% |
| Beta (5Y) | 0.78 | 0.85 |
| Max Drawdown (5Y) | -54.32% | -70.34% |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| Sharpe Ratio (1Y) | 0.81 | 0.34 |
| Sortino Ratio (1Y) | 1.23 | 0.54 |
Profitability
ROE (TTM)
Edwards Lifesciences (EW) posts ROE of 9.33%, roughly around the peer group’s normal range. Shareholders’ equity is producing a return that looks broadly typical for the industry.
EW
Health Care Equipment & Services industry group
9.33%
Group distribution
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Largest peers
- ISRG
- 17.93%
- SYK
- 16.02%
- UNH
- 15.77%
- MDT
- 10.65%
- EW
- 9.33%
- ABT
- 9.14%
- MCK
- --
Net Margin (TTM)
Edwards Lifesciences (EW) keeps 15.30% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.
EW
Health Care Equipment & Services industry group
15.30%
Group distribution
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Largest peers
- ISRG
- 25.54%
- EW
- 15.30%
- MDT
- 13.93%
- SYK
- 13.78%
- ABT
- 9.75%
- UNH
- 3.53%
- MCK
- 1.12%
Operating Margin (TTM)
Edwards Lifesciences (EW) turns 30.15% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.
EW
Health Care Equipment & Services industry group
30.15%
Group distribution
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Largest peers
- ISRG
- 33.29%
- EW
- 30.15%
- SYK
- 22.96%
- MDT
- 19.33%
- ABT
- 11.66%
- UNH
- 5.82%
- MCK
- 1.48%
Profitability Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| ROE (TTM) | 9.33% | 5.45% |
| ROA (TTM) | 8.77% | 3.17% |
| Net Margin (TTM) | 15.30% | 2.18% |
| Operating Margin (TTM) | 30.15% | 6.81% |
| Gross Margin (TTM) | 78.02% | 55.21% |
Growth
Revenue Growth
Edwards Lifesciences (EW) grew revenue 11.55%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.
EPS Growth
Edwards Lifesciences (EW) grew earnings per share -73.74%, in the lower peer quartile. Per-share profits are advancing more slowly than at most peers, so margins, costs, or share count deserve a closer look.
Growth Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| Revenue Growth (YoY) | 11.55% | 11.55% |
| Revenue Growth (3Y CAGR) | 10.77% | 10.83% |
| EPS Growth (YoY) | -73.74% | 4.88% |
| EPS Growth (3Y CAGR) | -9.14% | 14.59% |
Financial Strength
Current Ratio (MRQ)
Edwards Lifesciences (EW) has current ratio of 4.60, above the industry’s typical middle range. Liquidity looks ample versus peers, though an unusually high cushion can also mean idle current assets or inefficient working capital.
EW
Health Care Equipment & Services industry group
4.60
Group distribution
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Largest peers
- EW
- 4.60
- ISRG
- 3.33
- SYK
- 2.18
- MDT
- 2.07
- ABT
- 1.46
- MCK
- 0.90
- UNH
- 0.74
Debt / Equity (MRQ)
Edwards Lifesciences (EW) has debt-to-equity ratio of 0.06, in the lower-leverage quartile for its industry. Borrowing is modest relative to equity compared with most peers, which can leave more flexibility through a cycle.
EW
Health Care Equipment & Services industry group
0.06
Group distribution
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
Largest peers
- UNH
- 0.70
- SYK
- 0.66
- ABT
- 0.61
- MDT
- 0.55
- EW
- 0.06
- ISRG
- --
- MCK
- --
Financial Strength Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| Current Ratio (MRQ) | 4.60 | 1.98 |
| Debt / Equity (MRQ) | 0.06 | 0.58 |
| Net Debt / EBITDA | -1.88 | 2.04 |
Dividends
Dividend Yield (TTM)
Edwards Lifesciences (EW) pays no dividend, leaving dividend yield at 0.00% this period. Shareholders may still receive value through reinvestment or buybacks, but there is no dividend income to compare here.
EW
Health Care Equipment & Services industry group
0.00%
Group distribution
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- MDT
- 2.72%
- UNH
- 2.29%
- ABT
- 2.22%
- SYK
- 1.05%
- MCK
- 0.32%
- EW
- 0.00%
- ISRG
- 0.00%
Dividend Payout Ratio (TTM)
Edwards Lifesciences (EW) paid no earnings out as dividends this period, leaving payout ratio at 0.00%. There is no dividend payout to size against earnings.
EW
Health Care Equipment & Services industry group
0.00%
Group distribution
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- ABT
- 92.54%
- MDT
- 70.02%
- UNH
- 51.71%
- SYK
- 37.49%
- MCK
- 8.77%
- EW
- 0.00%
- ISRG
- 0.00%
Dividend Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Edwards Lifesciences (EW) trades at P/E ratio of 59.38, in the richer earnings-multiple quartile for its industry. That premium needs support from growth, durable earnings, or stronger business quality.
EW
Health Care Equipment & Services industry group
59.38
Group distribution
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
Largest peers
- EW
- 59.38
- ISRG
- 54.75
- ABT
- 41.02
- SYK
- 34.70
- MCK
- 27.36
- MDT
- 25.01
- UNH
- 22.50
P/S Ratio (TTM)
Edwards Lifesciences (EW) trades at 8.80 on P/S ratio, in the higher sales-valuation quartile. Investors are paying up for each dollar of revenue, so stronger margins, growth, or revenue quality need to carry that price.
EW
Health Care Equipment & Services industry group
8.80
Group distribution
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
Largest peers
- ISRG
- 13.82
- EW
- 8.80
- SYK
- 4.72
- ABT
- 3.95
- MDT
- 3.47
- UNH
- 0.78
- MCK
- 0.29
P/B Ratio (MRQ)
Edwards Lifesciences (EW) trades at 5.41 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.
EW
Health Care Equipment & Services industry group
5.41
Group distribution
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Largest peers
- ISRG
- 9.82
- EW
- 5.41
- SYK
- 5.29
- ABT
- 3.73
- UNH
- 3.60
- MDT
- 2.59
- MCK
- -30.85
Valuation Metrics
| Metric | Current stock: EW | Industry group median |
|---|---|---|
| P/E Ratio (TTM) | 59.38 | 29.93 |
| P/S Ratio (TTM) | 8.80 | 2.13 |
| P/B Ratio (MRQ) | 5.41 | 3.00 |
| Free Cash Flow Yield (TTM) | 1.95% | 3.50% |